Canagliflozin Hydrate Tablets 100mg (Canaglu® / カナグル錠100mg)

JPY ¥17,000

Japanese SGLT2 Inhibitor (Canagliflozin Hydrate 100mg). Oral tablet for once-daily administration before or after breakfast; indicated for type 2 diabetes mellitus and chronic kidney disease complicated by type 2 diabetes. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Tanabe Pharma Corporation, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥15,640
10 - 19 12% JPY ¥14,960
20 + 18% JPY ¥13,940
SKU: CNG-100-TAB Category:

Description

Product Overview / 商品概要

Canaglu Tablets 100mg (カナグル錠100mg)
Generic: Canagliflozin Hydrate / カナグリフロジン水和物
Therapeutic Category: SGLT2 Inhibitor / SGLT2阻害剤
Manufactured by: Tanabe Pharma Corporation / 田辺ファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Canagliflozin Hydrate 102mg (as Canagliflozin 100mg) per tablet / 1錠中 カナグリフロジン水和物102mg(カナグリフロジンとして100mg)
Additives: D-Mannitol, Hydroxypropylcellulose, Croscarmellose Sodium, Sodium Stearyl Fumarate, Talc, Polyvinyl Alcohol (partially saponified), Macrogol 4000, Titanium Oxide, Yellow Ferric Oxide, Ferric Oxide / D-マンニトール、ヒドロキシプロピルセルロース、クロスカルメロースナトリウム、フマル酸ステアリルナトリウム、タルク、ポリビニルアルコール(部分けん化物)、マクロゴール4000、酸化チタン、黄色三二酸化鉄、三二酸化鉄
Appearance: Light yellow film-coated tablet; diameter 7.6mm, thickness 3.4mm, weight 144.3mg
外観: うすい黄色・フィルムコーティング錠、直径7.6mm、厚さ3.4mm、重量144.3mg

Indications / 効能効果

EN: Type 2 diabetes mellitus; Chronic kidney disease complicated by type 2 diabetes mellitus (excluding patients with end-stage renal failure or those undergoing dialysis)
JA: 2型糖尿病、2型糖尿病を合併する慢性腎臓病(ただし、末期腎不全又は透析施行中の患者を除く)

Dosage and Administration / 用法用量

EN: Usual adult dose: 100mg as canagliflozin once daily, administered orally before or after breakfast.
JA: 通常、成人にはカナグリフロジンとして100mgを1日1回朝食前又は朝食後に経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; patients with severe ketosis, diabetic coma, or pre-coma; patients with severe infection, perioperative status, or serious trauma
JA: 本剤の成分に対し過敏症の既往歴のある患者、重症ケトーシス・糖尿病性昏睡又は前昏睡の患者、重症感染症・手術前後・重篤な外傷のある患者

Regulatory Information / 規制情報

Approval No.: 22600AMX00744
Sales Started: September 2014 / 2014年9月
Classification Code: 873969
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10], 500 tablets [10 tablets (PTP) x 50], 140 tablets [14 tablets (PTP) x 10], 500 tablets [bulk]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Canagliflozin Hydrate Tablets 100mg (Canaglu® / カナグル錠100mg)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Canagliflozin Hydrate Tablets 100mg (Canaglu®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.